Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.46 |
| ▸ | NPC1 | O15118 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | VHL | P40337 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18031837 | 0.88 | POLB (0.50) | RAB9ANPC1ALDH1A1SMN1; SMN2EPHX2 | |
| SCHEMBL16907558 | 0.87 | RAB9A (0.45) | RAB9ANPC1ALDH1A1SMN1; SMN2EPHX2 | |
| SCHEMBL6404261 | 0.83 | TDP1 (0.50) | RAB9ANPC1ALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL6408026 | 0.82 | NPC1 (0.50) | RAB9ANPC1ALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL4013192 | 0.81 | EPHX2 (0.44) | RAB9ANPC1ALDH1A1SMN1; SMN2EPHX2 | |
| SCHEMBL6402461 | 0.80 | PPARA (0.49) | RAB9ANPC1ALDH1A1SMN1; SMN2EPHX2 | |
| SCHEMBL5297276 | 0.80 | VHL (0.42) | RAB9ANPC1ALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL6404146 | 0.80 | EPHX2 (0.43) | RAB9ANPC1ALDH1A1SMN1; SMN2EPHX2 | |
| SCHEMBL6403020 | 0.79 | NPC1 (0.52) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL6405222 | 0.79 | SMN1; SMN2 (0.59) | RAB9ANPC1ALDH1A1SMN1; SMN2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050171358-A1 | Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide | SDS BIOTECH K.K. (JP) | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171358-A1 | Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide | AHR, ERG28, CYP1A2 | RAB9A 4044/4885NPC1 1915/4885ALDH1A1 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.